Racial differences have been observed in SSc susceptibility and severity, with black patients exhibiting higher TGF‐β expression and lower Cav‐1 levels compared to white individuals, highlighting the need for personalized treatment strategies [86]. Here, CAV1 is linked to systemic sclerosis.